IL2 and neoplasm: Among the various cytokines, the combination of CART cells and IL-15 or IL-21 administration mediated the best anti-tumor response, followed by IL-2 and IL-7, whereas IL-18 and only CART cells treated mice had the heaviest tumor burden (Figure 7C).